(Total Views: 577)
Posted On: 12/10/2020 2:30:54 PM
Post# of 72447
Got a tweet reply from Vijay Gupta (data scientist aware of Brilacidin progress) suggesting Remdesivir is not ideal.
"Innovation should try out Brilacidin in combination with Favipiravir because Remdesivir toxicity is making many clinicians wary of Remdesivir."
"Innovation should try out Brilacidin in combination with Favipiravir because Remdesivir toxicity is making many clinicians wary of Remdesivir."
(0)
(0)
